Vabysmo (faricimab, Roche), has been listed on the Pharmaceutical Benefits Scheme (PBS) for the treatment of approximately 20,000 Australians living with macular oedema secondary

A New Zealand study has examined the frequency of recurrences, risk factors, and long-term clinical outcomes in subjects with herpes zoster ophthalmicus (HZO).

A United Kingdom study of glaucoma patients has found ethnicity is strongly associated with differing perceptions about the health outcomes that matter.

Associate Professor Smita Agarwal has become the first ophthalmologist to engage mivision to produce patient facing videos to introduce her services and inform about